Cargando…
Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea
Although convalescent plasma (CP) transfusion was prioritized among potential Ebola treatments by the World Health Organization, there were concerns on the feasibility of its implementation. We report on the successful organization of donor mobilization and plasma collection as part of the Ebola-Tx...
Autores principales: | Delamou, Alexandre, Haba, Nyankoye Yves, Mari-Saez, Almudena, Gallian, Pierre, Ronse, Maya, Jacobs, Jan, Camara, Bienvenu Salim, Kadio, Kadio Jean-Jacques Olivier, Guemou, Achille, Kolie, Jean Pe, De Crop, Maaike, Chavarin, Patricia, Jacquot, Chantal, Lazaygues, Catherine, De Weggheleire, Anja, Lynen, Lutgarde, van Griensven, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014273/ https://www.ncbi.nlm.nih.gov/pubmed/27430546 http://dx.doi.org/10.4269/ajtmh.15-0890 |
Ejemplares similares
-
Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015
por: van Griensven, Johan, et al.
Publicado: (2016) -
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field
por: van Griensven, Johan, et al.
Publicado: (2016) -
What motivates Ebola survivors to donate plasma during an emergency clinical trial? The case of Ebola-Tx in Guinea
por: Ronse, Maya, et al.
Publicado: (2018) -
The Plasma Mobile, ‘A gift from heaven’: The impact of health technology transfer on trial perceptions and expectations during the Ebola-Tx Trial, Conakry
por: Marí Sáez, Almudena, et al.
Publicado: (2020) -
Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014–2015 outbreak
por: Edwards, Tansy, et al.
Publicado: (2016)